John Ochsner Heart and Vascular Institute
Heart Valve Program
Ochsner: An International Leader in Heart Care
Ochsner Health System is a long-time leader in heart care, with an international, national, and regional reputation for excellence. Through the John Ochsner Heart and Vascular Institute, we offer advanced cardiac programs that meet the highest standards in patient care, research, and education. Ochsner provides a continuum of patient care – diagnosis, treatment, surgery, non-surgical catheter-based procedures, and rehabilitation – unmatched in our region.
One of our highly specialized programs is the Heart Valve Program.
To download a brochure, click here.
Ochsner Heart Care Awarded for Top-Quality
- One of America’s Best Hospitals, among the top 25 hospitals nationally in Heart & Heart Surgery, by U.S. News and World Report
- One of the Top 15 Major Teaching Hospitals from the 100 Top Hospitals® by Thomson Reuters National Benchmark Study
- HealthGrades® Five-Stars for Coronary Interventional Procedures and Treatment of Heart Attack. Ochsner was among the top five of Louisiana hospitals in Overall Cardiac Services and Coronary Interventional Procedures.
Internationally Recognized for Heart Valve Repairs
The Heart Valve Program brings together a team of highly skilled cardiologists, surgeons and other medical professionals who work together to find the best solution for the individual patient. They deliver advanced medical and surgical care and are pioneers in cutting-edge research, especially in minimally invasive techniques. As leaders in clinical care, teaching and research, we provide the full range of patient care for heart valve diseases. The Heart Valve Program's multidisciplinary team’s experience and unique collaboration help to ensure the best possible specialized care for each patient.
Clinical Trial: Minimally Invasive Repair for Aortic Stenosis
The Heart Valve Program team offers more cutting-edge technologies than ever before.
Ochsner is one of only 22 hospitals nationwide and the only Gulf Coast hospital to participate in the PARTNER II clinical trial. Begun in August 2009, the trial uses the SAPIEN Transcatheter Heart Valve Device and delivery systems to treat patients with severe aortic stenosis (narrowing of the aortic valve, a common abnormality).
This dramatic procedure highlights Ochsner’s continuing efforts to offer advances that enhance patient care. As a minimally invasive alternative to open-heart surgery, it is designed to reduce the risks of surgery and shorten recovery time. One aspect of the investigational trial is replacing the aortic valve without an incision in the chest or need for a bypass machine. The procedure is performed in a state-of-the-art cardiac catheterization laboratory on a “beating heart.”
To read more about this clinical trial, click here.
Ochsner In the News
Dr. Stephen Ramee discuss the new heart valve implant process and what it means for patients.
